PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 15 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extracts of C. giganteum seeds showed significant antitussive properties in guinea pig models [PMID:20435131, PMID:29738848]
Oral administration of the biflavonoid CGY-1 (20 and 40 mg/kg) improved memory deficits in scopolamine-treated mice, as evidenced by shortened escape latency in the Morris water maze and increased freezing times in fear conditioning tests [PMID:30594789]
Evidence summary
PubMed sources
- 1.PMID: 38475495 (2024) — Time-Course Transcriptomic Analysis Reveals Molecular Insights into the Inflorescence and Flower Development of Cardiocrinum giganteum. · Plants (Basel, Switzerland)
- 2.PMID: 29738848 (2018) — Isolation of novel biflavonoids from Cardiocrinum giganteum seeds and characterization of their antitussive activities. · Journal of ethnopharmacology
- 3.PMID: 40427770 (2025) — Changes in the Distribution Range of the Genus Cardiocrinum in China Under Climate Change and Human Activities. · Biology
- 4.PMID: 40597596 (2025) — Assembly and comparative analysis of the complete mitochondrial genome of Cardiocrinum giganteum: a primitive Liliaceae group with significant scientific research value. · BMC genomics
- 5.PMID: 42113267